Literature DB >> 10542206

Biochemical characterization of various catalytic complexes of the brain platelet-activating factor acetylhydrolase.

H Manya1, J Aoki, H Kato, J Ishii, S Hino, H Arai, K Inoue.   

Abstract

Brain intracellular platelet-activating factor acetylhydrolase (PAF-AH) isoform I is a member of a family of complex enzymes composed of mutually homologous alpha(1) and alpha(2) subunits, both of which account for catalytic activity, and the beta subunit. We previously demonstrated that the expression of one catalytic subunit, alpha(1), is developmentally regulated, resulting in a switching of the catalytic complex from alpha(1)/alpha(2) to alpha(2)/alpha(2) during brain development (Manya, H., Aoki, J., Watanabe, M., Adachi, T., Asou, H., Inoue, Y., Arai, H., and Inoue, K. (1998) J. Biol. Chem. 273, 18567-18572). In this study, we explored the biochemical differences in three possible catalytic dimers, alpha(1)/alpha(1), alpha(1)/alpha(2), and alpha(2)/alpha(2). The alpha(2)/alpha(2) homodimer exhibited different substrate specificity from the alpha(1)/alpha(1) homodimer and the alpha(1)/alpha(2) heterodimer, both of which showed similar substrate specificity. The alpha(2)/alpha(2) homodimer hydrolyzed PAF and 1-O-alkyl-2-acetyl-sn-glycero-3-phosphorylethanolamine (AAGPE) most efficiently among 1-O-alkyl-2-acetyl-phospholipids. In contrast, both alpha(1)/alpha(1) and alpha(1)/alpha(2) hydrolyzed 1-O-alkyl-2-acetyl-sn-glycero-3-phosphoric acid more efficiently than PAF. AAGPE was the poorest substrate for these enzymes. The beta subunit bound to all three catalytic dimers but modulated the enzyme activity in a catalytic dimer composition-dependent manner. The beta subunit strongly accelerated the enzyme activity of the alpha(2)/alpha(2) homodimer but rather suppressed the activity of the alpha(1)/alpha(1) homodimer and had little effect on that of the alpha(1)/alpha(2) heterodimer. The (His(149) to Arg) mutant beta, which has been recently identified in isolated lissencephaly sequence patients, lost the ability to either associate with the catalytic complexes or modulate their enzyme activity. The enzyme activity of PAF-AH isoform I may be regulated in multiple ways by switching the composition of the catalytic subunit and by manipulating the beta subunit.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10542206     DOI: 10.1074/jbc.274.45.31827

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Metabolic profiling reveals PAFAH1B3 as a critical driver of breast cancer pathogenicity.

Authors:  Melinda M Mulvihill; Daniel I Benjamin; Xiaodan Ji; Erwan Le Scolan; Sharon M Louie; Alice Shieh; McKenna Green; Tara Narasimhalu; Patrick J Morris; Kunxin Luo; Daniel K Nomura
Journal:  Chem Biol       Date:  2014-06-19

Review 2.  The metabolic serine hydrolases and their functions in mammalian physiology and disease.

Authors:  Jonathan Z Long; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2011-06-23       Impact factor: 60.622

Review 3.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

Review 4.  A PLA1-2 punch regulates the Golgi complex.

Authors:  Marie E Bechler; Paul de Figueiredo; William J Brown
Journal:  Trends Cell Biol       Date:  2011-11-28       Impact factor: 20.808

5.  Intracellular erythrocyte platelet-activating factor acetylhydrolase I inactivates aspirin in blood.

Authors:  Gang Zhou; Gopal K Marathe; Belinda Willard; Thomas M McIntyre
Journal:  J Biol Chem       Date:  2011-08-15       Impact factor: 5.157

6.  Novel isoforms of intracellular platelet activating factor acetylhydrolase (PAFAH1b2) in human testis; encoded by alternatively spliced mRNAs.

Authors:  Bruce T Scott; Nels Olson; George L Long; Edwin G Bovill
Journal:  Prostaglandins Other Lipid Mediat       Date:  2007-11-09       Impact factor: 3.072

7.  Crystal structures of brain group-VIII phospholipase A2 in nonaged complexes with the organophosphorus nerve agents soman and sarin.

Authors:  Todd M Epstein; Uttamkumar Samanta; Stephen D Kirby; Douglas M Cerasoli; Brian J Bahnson
Journal:  Biochemistry       Date:  2009-04-21       Impact factor: 3.162

Review 8.  Phospholipase A2 biochemistry.

Authors:  John E Burke; Edward A Dennis
Journal:  Cardiovasc Drugs Ther       Date:  2008-10-18       Impact factor: 3.727

9.  Aspirin hydrolysis in plasma is a variable function of butyrylcholinesterase and platelet-activating factor acetylhydrolase 1b2 (PAFAH1b2).

Authors:  Gang Zhou; Gopal K Marathe; Jaana Hartiala; Stanley L Hazen; Hooman Allayee; W H Wilson Tang; Thomas M McIntyre
Journal:  J Biol Chem       Date:  2013-03-18       Impact factor: 5.157

10.  PAFAH Ib phospholipase A2 subunits have distinct roles in maintaining Golgi structure and function.

Authors:  Marie E Bechler; William J Brown
Journal:  Biochim Biophys Acta       Date:  2012-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.